Form 4: Centene Director Kenneth Tanji Receives Stock Grant

Centene Corporation Director Kenneth Tanji was granted 3,992 restricted stock units as part of an equity compensation award.

Summary

• Director Kenneth Tanji acquired 3,992 shares of Centene Corporation common stock.
• The transaction occurred on May 12, 2026.
• The shares were granted as restricted stock units (RSUs) with a price of $0.
• Following this transaction, the director's total beneficial ownership is 11,909 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• The director's increased equity stake aligns personal interests with those of shareholders.

Negatives

• None identified.

Risks

• The vesting of these shares is subject to the director's continued service until the earlier of May 12, 2027, or the next annual meeting.

Future Outlook

The restricted stock units are scheduled to vest in full on May 12, 2027, or the date of the next annual meeting of stockholders, whichever occurs first.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and alignment with shareholder value in the managed healthcare sector.

Comparison to Industry Standards

• The grant of restricted stock units to board members is consistent with standard compensation practices for S&P 500 healthcare companies.
• The vesting schedule aligns with typical one-year director equity retention cycles observed in the industry.

Stakeholder Impact

• Shareholders benefit from the increased alignment of director interests with company performance.

Next Steps

• Vesting of the 3,992 restricted stock units on May 12, 2027, or the next annual meeting.

Key Dates

Keywords

Centene, CNC, Form 4, Insider Trading, Director Compensation, Equity Grant